BioMark Diagnostics(TSE:BUX)
CA$0.420.00 (0.00%)
TSE:BUX
BioMark Diagnostics financials statements
CA$0.42
At close:0.00 (0.00%)
Want to see TSE:BUX full AI Analyst Report?
BioMark Diagnostics (BUX) Income Statement
3 Followers
BioMark Diagnostics Income Statement
Last quarter (Q4 2026), BioMark Diagnostics's total revenue was C$7.01K, a decrease of 82.03% from the same quarter last year. In Q4, BioMark Diagnostics's net income was C$-199.47K. See BioMark Diagnostics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| C$ 59.79K | C$ 154.22K | C$ 163.22K | C$ 153.49K | C$ 0.00 | |
| C$ -322.49K | C$ 154.22K | C$ 163.22K | C$ -232.70K | C$ -13.69K | |
| C$ 1.55M | C$ 2.06M | C$ 1.48M | C$ 1.89M | C$ 1.08M | |
| Depreciation and Amortization | C$ 382.28K | C$ 401.27K | C$ 393.17K | C$ 386.20K | C$ 13.69K |
| C$ -1.49M | C$ -1.46M | C$ -919.05K | C$ -1.35M | C$ -1.08M | |
| C$ -1.87M | C$ -1.91M | C$ -1.32M | C$ -1.84M | C$ -1.09M | |
| C$ 268.36K | C$ -19.14K | C$ -110.67K | C$ -110.15K | C$ -596.00 | |
| C$ -1.60M | C$ -1.93M | C$ -1.43M | C$ -1.84M | C$ -1.09M | |
| C$ -1.48M | C$ -1.93M | C$ -1.43M | C$ -1.84M | C$ -1.09M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.01 | C$ -0.02 | C$ -0.02 | C$ -0.02 | C$ -0.01 |
| Diluted EPS | C$ -0.01 | C$ -0.02 | C$ -0.02 | C$ -0.02 | C$ -0.01 |
| Weighted Average Shares Outstanding | 105.09M | 85.24M | 85.24M | 82.78M | 73.30M |
| Weighted Average Shares Outstanding (Diluted) | 105.09M | 85.24M | 85.24M | 82.78M | 73.30M |
Currency in CAD

